Vimarsana
Biggest News Aggregation in the World

Page 5 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Sciences Today - Breaking & Trending Today

BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024 - Vimarsana News

BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024

MINNEAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and...

BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Vimarsana News

BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

MINNEAPOLIS, Dec. 21, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Kim Kelderman, current Chief Operating Officer, and Chief Executive Officer effective February 1, 2024, will...

BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY - Vimarsana News

BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration...

Accelerating advances in antibody therapy - Vimarsana News

Accelerating advances in antibody therapy

Creasallis, a UK-based start-up focused on enhancing the penetration of therapeutic antibodies into tumours, has received a boost from Integra Biosciences. Click to read more...

Accelerating antibody therapy with INTEGRA pipettes - Vimarsana News

Accelerating antibody therapy with INTEGRA pipettes

INTEGRA Biosciences has awarded 50 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000 and various lab accessories to UK-based start-up Creasallis, helping to accelerate its pioneering research into improving the penetration of therapeutic antibodies into tumors.